Single-agent bevacizumab in the treatment of recurrent or refractory pediatric low-grade glioma: A single institutional experience-Reference-Cited by-同舟云学术

Single-agent bevacizumab in the treatment of recurrent or refractory pediatric low-grade glioma: A single institutional experience

Published:2018-05-11 Issue:9 Volume:65 Page:e27234
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Gorsi Hamza S.¹²^ORCID,Khanna Paritosh C.²³,Tumblin Mark²⁴,Yeh-Nayre Lanipua²⁴,Milburn Mehrzad²⁴,Elster Jennifer D.²⁴,Crawford John R.¹²⁴

Affiliation:

1. Department of Neurosciences; University of California San Diego; La Jolla California

2. Rady Children's Hospital; San Diego California

3. Department of Radiology; University of California San Diego; La Jolla California

4. Department of Pediatrics; Division of Hematology Oncology; University of California San Diego; La Jolla California

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference9 articles.

1. Pediatric gliomas: current concepts on diagnosis, biology, and clinical management;Sturm;J Clin Oncol,2017

2. A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population based cohort study (CCLG CNS9702);Stokland;Neuro Oncol,2010

3. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group;Ater;J Clin Oncol,2012

4. Phase II study of weekly vinblastine in recurrent or refractory pediatric low grade glioma;Bouffet;J Clin Oncol,2012

5. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group;Nicholson;Cancer,2007

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic chemotherapy in pediatric neurooncology: insight the problem. A review;Journal of Modern Oncology;2024-07-03

2. Molecular-targeted therapy for childhood low-grade glial and glioneuronal tumors;Child's Nervous System;2024-06-15

3. The safety and efficacy of bevacizumab in treatment of recurrent low-grade glioma: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2024-05-11

4. Use of bevacizumab in pediatric low-grade glioma: Ten-year experience in a single center;EJC Paediatric Oncology;2023-12

5. Optic Pathway Gliomas in Pediatric Population—Current Approach in Diagnosis and Management: Literature Review;Journal of Clinical Medicine;2023-10-24